ADHD Flashcards

1
Q

examples of psychostimulants

A

Include: cocaine, amphetamine, methamphetamine (look like dopamine so block the transporters).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

action of psychostimulants

A

Block or reverse monoamine transporters (Massive increase in synaptic concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

presentation of the action of psychostimulants

A

Alertness, euphoria, bruxism, weight loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

overdose of psychostimulants

A
  • Psychosis, Cardiac effects, Stroke (vasoconstriction), Seizures
  • Treated with Haloperidol

“Withdrawal” results in ravenous appetite, exhaustion, and mental depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GENERAL PROPERTIES OF STIMULANT DRUGS:

A

Increased: Arousal, attention, vigilance, movement, wakefulness, confidence

Euphoria, stress and anxiety, appetite suppression, addiction?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

METHYLPHENIDATE (RITALIN): mechanisms

A

Similar mechanism of action to Amphetamine, Cocaine etc.
- Less potent
- Slower acting (especially in clinical preparations)
- Blocks transporters (not reverse)
- No effect on serotonin
Abused recreationally
Less addictive? (Difficult to obtain reliable data)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

atomoxetine mechanisms

A

Blocks only the noradrenaline transporter (Increase attention)

Not addictive
- (No dopamine action?)
- Not scheduled
- (Prescription-only)

Not a cognitive enhancer in healthy individuals (?) (Limited abuse potential)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Guanfacine

A

Directly stimulates adrenergic receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

caffeine action

A

Blocks adenosine receptors (Adenosine normally produce ‘sleepiness’). Indirectly results in increased noradrenaline release (Mechanism unclear). Very legal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ADHD prevalence and challenges

A

Restless, impulsive, difficulty concentrating (Age inappropriate)
- 7% worldwide

Problems with Response Inhibition
The ability “to resist internal or external interferences to achieve goal directed behaviours” (Barkley 1997)

Challenges with Working Memory
- Visuospatial more than verbal
- Improves with age
- Improved by methylphenidate

Response Inhibition causes, or is caused by, working memory problems?
Neurobiology poorly understood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 types of ADHD

A

ADHD-PI
ADHD-PHI
ADHD-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ADHD-PI

A

Formerly known as Attention Deficit Disorder (ADD)
- ‘Predominantly Inattentive’
- Difficulty maintaining focus
- Difficulty following instructions
- Easily distracted
- Forgetful
- ‘Doesn’t listen’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADHD-PHI

A
  • Predominantly Hyperactive-Impulsive Presentation
  • Restless, interrupt others
  • Excessive fidgeting or tapping
  • Very talkative
  • Difficulty remaining seated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ADHD-C

A
  • Combined Presentation
  • Most common type
  • Mixture of both presentations (6 or more symptoms from each type)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

EBP

A

The conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients (Sackett et al., 1996).

Cochrane: Reviews of research for evidence for a range of clinical presentations.

NICE guidance: Clinical guidelines for treatment pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GENERATING EVIDENCE: PICO
Asking clinical research questions; PICO

A

Population
- Who?
- Specific feature?
- Other features e.g. comorbidities?
- Demographics
Intervention
- Treatment
- Exposure
Comparison
- Placebo
- Existing best treatment
- Combination
Outcome
- Get better?
- Slow progression?
- Test/function scores?
- What type of data?

17
Q

ADHD population questions

A
  • ADHD more likely (Family history)
  • ADHD under-diagnosed/recognised in women and girls
  • Diagnosis made by specialist
18
Q

TREATMENT OPTIONS for ADHD

A

Environmental options first then medication
- methyphenidate (if does not work, or is ‘not tolerated’ then)
- lisdexamfetamine (if does not work, or is ‘not tolerated’ then)
- atomoxetine or guanfacine

  • ‘patient preferences re; stimulants’
  • co-morbid conditions (treat first if more severe)
  • extended release vs short action versions?
  • side effects
19
Q

SOME SIDE EFFECTS of methylphenidate, lisdexamfetamine, atomoxetine

A
  • Appetite decreased, sleep disorders, weight decreased
  • Population considerations?
20
Q

cognitive enhancement

A

Diverse in action

Cognitive enhancing drugs have biggest effects where performance is already lower
- Ceiling of performance
- Limited effects in people without ADHD